☰

Nicoleta C. Arva, Ph.D. - Publications

Affiliations: 
2006 City University of New York, New York, NY, United States 
Area:
Molecular Biology, Cell Biology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Isales MC, Mohan LS, Quan VL, Garfield EM, Zhang B, Shi K, Arva N, Beaubier N, Yazdan P, White K, Taxter TJ, Gerami P. Distinct Genomic Patterns in Pigmented Epithelioid Melanocytoma: A Molecular and Histologic Analysis of 16 Cases. The American Journal of Surgical Pathology. PMID 30475255 DOI: 10.1097/Pas.0000000000001195  0.347
2016 Margaryan NV, Gilgur A, Seftor EA, Purnell C, Arva NC, Gosain AK, Hendrix MJ, Strizzi L. Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi. International Journal of Molecular Sciences. 17. PMID 27011171 DOI: 10.3390/Ijms17030418  0.404
2015 Yélamos O, Arva NC, Obregon R, Yazdan P, Wagner A, Guitart J, Gerami P. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children. The American Journal of Surgical Pathology. 39: 405-15. PMID 25517953 DOI: 10.1097/Pas.0000000000000351  0.306
2013 Okoro DR, Arva N, Gao C, Polotskaia A, Puente C, Rosso M, Bargonetti J. Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator. Plos One. 8: e77643. PMID 24147044 DOI: 10.1371/Journal.Pone.0077643  0.693
2013 Okoro D, Gao C, Puente C, Polotskaia A, Arva N, Rosso M, Bargonetti J. Abstract 1909: Multiple Mdm2 isoforms promote tumorigenesis, disrupt mammary tissue architecture, and are endogenously expressed in cancers. Cancer Research. 73: 1909-1909. DOI: 10.1158/1538-7445.Am2013-1909  0.711
2008 Arva NC, Talbott KE, Okoro DR, Brekman A, Qiu WG, Bargonetti J. Disruption of the p53-Mdm2 complex by nutlin-3 reveals different cancer cell phenotypes Ethnicity and Disease. 18: S2-1-S2-8. PMID 18646312  0.75
2007 Boamah EK, White DE, Talbott KE, Arva NC, Berman D, Tomasz M, Bargonetti J. Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathways. Acs Chemical Biology. 2: 399-407. PMID 17530733 DOI: 10.1021/Cb700060T  0.71
2006 White DE, Talbott KE, Arva NC, Bargonetti J. Mouse double minute 2 associates with chromatin in the presence of p53 and is released to facilitate activation of transcription. Cancer Research. 66: 3463-70. PMID 16585169 DOI: 10.1158/0008-5472.Can-05-1381  0.773
2005 Arva NC, Gopen TR, Talbott KE, Campbell LE, Chicas A, White DE, Bond GL, Levine AJ, Bargonetti J. A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells. The Journal of Biological Chemistry. 280: 26776-87. PMID 15908423 DOI: 10.1074/Jbc.M505203200  0.6
2004 Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 119: 591-602. PMID 15550242 DOI: 10.1016/J.Cell.2004.11.022  0.736
Show low-probability matches.